Boris L. Zaïtra

Head of Corporate Business Development (Member of the enlarged CEC since 2024)

Nationality
France

Year of Birth
1972

1995
Ecole Polytechnique (X92), France, Engineering, M.Sc.

2009
Harvard Business School, Advanced Management Programme (AMP 177)

1995–1999
JP Morgan, Mergers & Acquisitions, Associate

1999–2005
Duke Street Capital, Partner

2005–2012
Airbus Group, Head of Mergers & Acquisitions, Corporate Vice-President

2012–2024
Roche Basel, Head of Group Business Development / M&A

Since 2024
Roche, Basel, Head of Corporate Business Development

–

Since 2026
Member of the Board of Directors, Viellard Migeon & Compagnie, France

Since 2025
Member of the Board of Directors, Chugai Pharmaceutical Co., Ltd

–

Discover more

Board of Directors
About Roche
The Board of Directors' composition and the curricula vitae of its members.
Executive Committee
About Roche
The Executive Committee's composition and the curricula vitae of its members.
Annual General Meeting
About Roche
The General Meeting is convened by the Board of Directors, together with its agenda and the proposals of the Board of Directors and the shareholders.
Board Committees
About Roche
Our Board of Directors has delegated certain matters to four committees for detailed attention.
Code of conduct
About Roche
The Roche Group Code of Conduct states the expectations Roche as an employer has towards his employees and sets forth the standards for business behaviour that apply throughout the Roche Group.
Investors
Investors
We are committed to delivering value for all our stakeholders through continuous innovation, groundbreaking solutions, trust and sustainable business practices.